| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
|
Ciofu, Oana
|
|
2015
|
85 |
C |
p. 7-23
17 p.
|
artikel
|
| 2 |
Clinical applications of pulmonary delivery of antibiotics
|
Flume, Patrick A.
|
|
2015
|
85 |
C |
p. 1-6
6 p.
|
artikel
|
| 3 |
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J.Weers, Adv. Drug Deliv. Rev. (2014), http://dx.doi.org/ 10.1016/j.addr.2014.08.013
|
de Boer, A.H.
|
|
2015
|
85 |
C |
p. e1-e2
nvt p.
|
artikel
|
| 4 |
Comment on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Inhaled antimicrobial therapy — Barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Cipolla, David
|
|
2015
|
85 |
C |
p. e6-e7
nvt p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2015
|
85 |
C |
p. ii-
1 p.
|
artikel
|
| 6 |
Imaging regional lung function: A critical tool for developing inhaled antimicrobial therapies
|
Dubsky, Stephen
|
|
2015
|
85 |
C |
p. 100-109
10 p.
|
artikel
|
| 7 |
Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead
|
Velkov, Tony
|
|
2015
|
85 |
C |
p. 65-82
18 p.
|
artikel
|
| 8 |
Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead
|
Chan, Hak-Kim
|
|
2015
|
85 |
C |
p. v-vii
nvt p.
|
artikel
|
| 9 |
Inhaled antimicrobial therapy – Barriers to effective treatment
|
Weers, Jeffry
|
|
2015
|
85 |
C |
p. 24-43
20 p.
|
artikel
|
| 10 |
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
|
Zhou, Qi (Tony)
|
|
2015
|
85 |
C |
p. 83-99
17 p.
|
artikel
|
| 11 |
Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy
|
Mukker, Jatinder Kaur
|
|
2015
|
85 |
C |
p. 57-64
8 p.
|
artikel
|
| 12 |
Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models
|
Hittinger, Marius
|
|
2015
|
85 |
C |
p. 44-56
13 p.
|
artikel
|
| 13 |
Reply to the comment by Cipolla et al. on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Weers, Jeffry
|
|
2015
|
85 |
C |
p. e8-e10
nvt p.
|
artikel
|
| 14 |
Reply to the comment by de Boer and Hoppentocht on: Inhaled Antimicrobial therapy – Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Weers, Jeffry
|
|
2015
|
85 |
C |
p. e3-e5
nvt p.
|
artikel
|
Tijdschrift beschrijving